TOKYO, Dec 18 (Reuters) - Japan’s Shionogi & Co said on Tuesday that it has applied to health regulators in the United States, Canada and Europe for approval of its HIV drug Dolutegravir. Shionogi developed Dolutegravir with a Viiv Healthcare, an AIDS drug joint venture between GlaxoSmithKline and Pfizer, in exchange for its rights to the drug.
The article was written on December 18th.
TOKYO, Dec 18 (Reuters) is when the article was written as it states in the first words of the sentence
( z1 write :ARG1 ( z2 article ) :time ( z3 date-entity :month 12 :day 18 ) )